These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mutations in the promoter region of methionine transporter gene Zhang Y; Wang S; Chen X; Cui P; Chen J; Zhang W mBio; 2024 Feb; 15(2):e0207323. PubMed ID: 38179948 [TBL] [Abstract][Full Text] [Related]
3. Deletion of Yang SS; Hu YB; Wang XD; Gao YR; Li K; Zhang XE; Chen SY; Zhang TY; Gu J; Deng JY Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28717039 [TBL] [Abstract][Full Text] [Related]
4. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria. Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321 [TBL] [Abstract][Full Text] [Related]
5. Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance. Minato Y; Thiede JM; Kordus SL; McKlveen EJ; Turman BJ; Baughn AD Antimicrob Agents Chemother; 2015 Sep; 59(9):5097-106. PubMed ID: 26033719 [TBL] [Abstract][Full Text] [Related]
6. The T120P or M172V mutation on Xu JT; Yu JF; Cheng T; Feng A; Yang P; Gu J; Yu HJ; Deng JY Emerg Microbes Infect; 2024 Dec; 13(1):2374030. PubMed ID: 39023395 [TBL] [Abstract][Full Text] [Related]
7. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis. Chakraborty S; Gruber T; Barry CE; Boshoff HI; Rhee KY Science; 2013 Jan; 339(6115):88-91. PubMed ID: 23118010 [TBL] [Abstract][Full Text] [Related]
8. Decreased Methylenetetrahydrofolate Reductase Activity Leads to Increased Sensitivity to Yu JF; Xu JT; Yang SS; Gao MN; Si HR; Xiong DY; Gu J; Wu ZL; Zhou J; Deng JY Antimicrob Agents Chemother; 2022 Jan; 66(1):e0146521. PubMed ID: 34780266 [TBL] [Abstract][Full Text] [Related]
9. Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents. Hajian B; Scocchera E; Shoen C; Krucinska J; Viswanathan K; G-Dayanandan N; Erlandsen H; Estrada A; Mikušová K; Korduláková J; Cynamon M; Wright D Cell Chem Biol; 2019 Jun; 26(6):781-791.e6. PubMed ID: 30930162 [TBL] [Abstract][Full Text] [Related]
10. Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis. Zhao F; Wang XD; Erber LN; Luo M; Guo AZ; Yang SS; Gu J; Turman BJ; Gao YR; Li DF; Cui ZQ; Zhang ZP; Bi LJ; Baughn AD; Zhang XE; Deng JY Antimicrob Agents Chemother; 2014; 58(3):1479-87. PubMed ID: 24366731 [TBL] [Abstract][Full Text] [Related]
11. Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis. Mathys V; Wintjens R; Lefevre P; Bertout J; Singhal A; Kiass M; Kurepina N; Wang XM; Mathema B; Baulard A; Kreiswirth BN; Bifani P Antimicrob Agents Chemother; 2009 May; 53(5):2100-9. PubMed ID: 19237648 [TBL] [Abstract][Full Text] [Related]
12. Whole genome sequencing reveals candidate genes involving in PAS resistance in M. Tuberculosis isolated from patients in Thailand. Dokladda K; Billamas P; Jaitrong S; Suwanakitti N; Phornsiricharoenphant W; Viratyosin W; Prammananan T World J Microbiol Biotechnol; 2023 Dec; 40(1):32. PubMed ID: 38057660 [TBL] [Abstract][Full Text] [Related]
13. [Mutations in the thymidylate synthase gene is a major mechanism in the para-aminosalicylic acid resistance of M. tuberculosis]. Zhang ZD; Zhao YL; Li ZH; Jia HY; Liu YH; Chen X; Liu ZQ; Du BP; Xing AY; Ma Y Zhonghua Jie He He Hu Xi Za Zhi; 2007 Sep; 30(9):683-5. PubMed ID: 18070553 [TBL] [Abstract][Full Text] [Related]
14. Targeting intracellular p-aminobenzoic acid production potentiates the anti-tubercular action of antifolates. Thiede JM; Kordus SL; Turman BJ; Buonomo JA; Aldrich CC; Minato Y; Baughn AD Sci Rep; 2016 Dec; 6():38083. PubMed ID: 27905500 [TBL] [Abstract][Full Text] [Related]
15. Multi-omics comparisons of p-aminosalicylic acid (PAS) resistance in folC mutated and un-mutated Mycobacterium tuberculosis strains. Wei W; Yan H; Zhao J; Li H; Li Z; Guo H; Wang X; Zhou Y; Zhang X; Zeng J; Chen T; Zhou L Emerg Microbes Infect; 2019; 8(1):248-261. PubMed ID: 30866779 [TBL] [Abstract][Full Text] [Related]
16. Antagonism of methionine in aminosalicylate-inhibition of Mycobacterium tuberculosis. HEDGECOCK LW J Bacteriol; 1958 Apr; 75(4):417-21. PubMed ID: 13525346 [No Abstract] [Full Text] [Related]
17. Antagonism of the inhibitory action of aminosalicylic acid on Mycobacterium tuberculosis by methionine, biotin and certain fatty acids, amino acids, and purines. HEDGECOCK LW J Bacteriol; 1956 Dec; 72(6):839-46. PubMed ID: 13398375 [No Abstract] [Full Text] [Related]
18. Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations. Wang W; Li S; Ge Q; Guo H; Shang Y; Ren W; Wang Y; Xue Z; Lu J; Pang Y Ann Clin Microbiol Antimicrob; 2022 Nov; 21(1):48. PubMed ID: 36335391 [TBL] [Abstract][Full Text] [Related]